Dual-tracer PSMA/FDG PET/CT for lesion detection and risk stratification in biochemical recurrence with negative

Linjie Bian1,2,3,4,5, Xuan Huang1,2,3,4,5, Bin Zhu1,2,3,4,5

  • 1Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, No. 270 Dong'an Road, Xuhui District, Shanghai, 200032, China.

Abstract